Insmed (INSM) Stock
Insmed (INSM) closed at $122.88 on Nov 16, 2026; its Tenet Score is 33 of 100 against 340 Healthcare peers.
24 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $122.88
- Nov 16, 2026
- Market cap
- $27.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 90.39 – 212.75
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 33/100
- Weak · 340 Healthcare peers
Industry: Drugs
Insmed Inc scores 33/100. Weak. Value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacte…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Biogen IncBIIB | 40 | $37.2B |
| Revolution Medicines IncRVMD | 39 | $36.1B |
| Zoetis IncZTS | 59 | $34.3B |
| Illumina IncILMN | 52 | $29.9B |
| Roivant Sciences LtdROIV | 43 | $28.0B |
| United Therapeutics CorpUTHR | 72 | $25.0B |
| Incyte Corp.INCY | 60 | $24.5B |
| Alnylam Pharmaceuticals IncALNY | 52 | $21.4B |
| Medpace Holdings IncMEDP | 59 | $18.1B |
| Ascendis Pharma A/SASND | 53 | $16.8B |
Compare Insmed with
Common questions
What sector and industry is Insmed in?
Insmed is in the Healthcare sector and the Drugs industry.
What is Insmed's Tenet Score?
Insmed's Tenet Score is 33 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




